Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02718066
Title Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors HUYA Bioscience International
Indications

lung non-small cell carcinoma

melanoma

renal cell carcinoma

Therapies

Chidamide + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.